Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial

IntroductionThe Chinese herbal compound formula, Shenqisuxin granule (SQSX), promotes neovascularization and prevents in-stent restenosis in modern pharmaceutical studies and is expected to provide an effective strategy for non-ST-segment elevation acute coronary syndrome (NSTEACS). Thus, this study...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Xiaoping Wu, Ming Guo, Shihua Shi, Shengnan Shi, Yanping Deng, Shenglan Wang, Yabing Wang, Peili Wang, Keji Chen
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2022-06-01
Serija:	Frontiers in Cardiovascular Medicine
Teme:	Shenqisuxin granule non-ST-segment elevation acute coronary syndrome intestinal flora randomized controlled trial Chinese herbs
Online dostop:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.888724/full
Oznake:	Označite Brez oznak, prvi označite!